...
首页> 外文期刊>Digestive Diseases and Sciences >Early diagnosis of hepatocellular carcinoma by MicroRNAs: Shining a light from the genome's 'dark matter'
【24h】

Early diagnosis of hepatocellular carcinoma by MicroRNAs: Shining a light from the genome's 'dark matter'

机译:MicroRNAs对肝细胞癌的早期诊断:从基因组的“暗物质”发出光芒

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatocellular carcinoma (HCC) is the leading cause of death among patients with chronic hepatitis and cirrhosis [1]. Chronic infection with hepatitis B virus (HBV) and/or hepatitis C virus (HCV) are the most frequent etiological factors for cirrhosis and accounts for approximately 50 and 25 % of all HCC cases, respectively [2]. Other important risk factors for HCC include alcohol consumption and HIV infection. Both are susceptible to exerting a more rapid progression from cirrhosis to HCC due to a synergistic effect in individuals with HBV and/or HCV infections [3]. Accordingly, 80-90 % of patients with HCC have an established background of chronic hepatitis and cirrhosis [4]; consequently, both conditions should be considered components of the HCC-associated multistep process.
机译:肝细胞癌(HCC)是慢性肝炎和肝硬化患者的主要死亡原因[1]。乙型肝炎病毒(HBV)和/或丙型肝炎病毒(HCV)的慢性感染是肝硬化的最常见病因,分别占所有HCC病例的约50%和25%[2]。肝癌的其他重要危险因素包括饮酒和感染艾滋病毒。由于对患有HBV和/或HCV感染的个体具有协同作用,两者都容易从肝硬化发展为HCC [3]。因此,80-90%的HCC患者具有慢性肝炎和肝硬化的确定背景[4];因此,这两个条件都应视为与HCC相关的多步过程的组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号